All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Exempt||2018-004208-20||A phase 1/2 study of GH001 in patients with treatment-resistant depression||2021-11-06||not-yet-due|
|Ongoing||2021-006861-39||A Phase 2 Clinical Trial of GH001 in Patients with Bipolar II Disorder and a Current Major Depressive Episode (GH001-BD-202)||not-yet-due|
|Ongoing||2021-006879-42||A phase 2 clinical trial of GH001 in patients with postpartum depression||not-yet-due|
|Ongoing||2022-000574-26||A randomized, double-blind, placebo-controlled, Phase 2b trial with an open-label extension to determine the safety and efficacy of GH001 in patients with treatment-resistant depression||not-yet-due|